Johnson

Johnson & Johnson Subsidiary Fined $1.64 Billion Over Misleading HIV Drug Promotions

by

Philadelphia, PA – A U.S. jury has ruled against a Johnson & Johnson subsidiary, ordering the pharmaceutical giant to pay $1.64 billion in a landmark case that accuses the company of misleading marketing practices related to its HIV treatments. This verdict marks one of the largest in a series of legal challenges faced by the company. The case revolved around the allegations that Janssen Pharmaceuticals, a unit of Johnson & Johnson, engaged in false and misleading promotion of its drugs used to treat HIV. The lawsuit claimed that the company failed to adequately warn patients … Read more

Federal Court Orders Johnson & Johnson Unit to Pay $1.64 Billion in Landmark Whistleblower HIV Drug Case

by

Trenton, New Jersey – A federal judge has mandated Johnson & Johnson’s Janssen Pharmaceuticals unit to pay a hefty $1.64 billion for allegedly marketing two HIV medications, Prezista and Intelence, for unapproved uses. This order followed a recent jury verdict that found the company liable under whistleblower lawsuit claims. U.S. District Judge Zahid Quraishi ruled that Janssen violated the federal False Claims Act, leading to a direct $360 million fine. The company also faces civil fines amounting to $1.28 billion, which calculates to $8,000 for each of the 159,574 false claims submitted to government programs … Read more

Johnson & Johnson Talc Trial Begins Amid Calls for Professionalism; LA Hires Firm for Wildfire Defense

by

Houston, TX — Opening statements initiated a pivotal two-week trial in Houston this week, deliberating the future of Johnson & Johnson’s bankruptcy claim linked to its talc products. The courtroom saga centers around whether to uphold or dismiss a chapter 11 bankruptcy filing by Johnson & Johnson’s subsidiary, Red River Talc. This move has been met with mixed reactions, signaling potential high stakes for the pharmaceutical giant. Central to the case are allegations that Johnson & Johnson’s talcum powder products are linked to ovarian cancer claims. U.S. Bankruptcy Judge Christopher Lopez of the Southern District … Read more

Breaking: Johnson & Johnson Poised to Announce Backing for Major Talc Settlement, Insider Confirms

by

Johnson & Johnson is reportedly on the verge of announcing its agreement to a substantial settlement regarding its talcum powder products, which have been the subject of numerous lawsuits alleging that they cause cancer. The health care giant has been under intense scrutiny for years due to claims that its talcum powders, including the iconic Johnson’s Baby Powder, contain asbestos, a known carcinogen. The move marks a critical step in addressing the myriad legal challenges that have tarnished the company’s reputation and cast a shadow over its product safety standards. Legal analysts suggest that the … Read more